Ball with a foam covered carcass and a method for making a ball with a foam covered carcass
    11.
    发明授权
    Ball with a foam covered carcass and a method for making a ball with a foam covered carcass 有权
    具有泡沫覆盖的胎体的球和用泡沫覆盖的胎体制造球的方法

    公开(公告)号:US07137915B2

    公开(公告)日:2006-11-21

    申请号:US11089002

    申请日:2005-03-24

    Applicant: Chun-Nan Lin

    Inventor: Chun-Nan Lin

    CPC classification number: A63B41/10 A63B45/00

    Abstract: A ball with a foam carcass has an inner bladder, a winding layer, a foam carcass layer, a colored rubber ink layer, and a leather layer. The inner bladder is hollow. The winding layer is attached to and covers the inner bladder. The colored rubber ink is brushed on and covers the foam carcass layer. The foam carcass layer with the colored rubber ink layer with the colored rubber ink is attached to and covers the winding layer to form a foam covered carcass. The foam covered carcass is vulcanized. The colored rubber ink layer covers the uneven foam-carcass layer to form an even foam covered carcass. The leather layer is attached to the foam covered carcass.

    Abstract translation: 具有泡沫胎体的球具有内囊,缠绕层,泡沫胎体层,着色橡胶油墨层和皮革层。 内囊是中空的。 缠绕层附着并覆盖内囊。 着色的橡胶墨水被刷涂并覆盖泡沫层。 具有着色橡胶墨水的着色橡胶油墨层的泡沫层层附着并覆盖卷绕层以形成泡沫覆盖的胎体。 泡沫覆盖的胎体硫化。 彩色橡胶油墨层覆盖不均匀的泡沫 - 胎体层,以形成均匀的泡沫覆盖的胎体。 皮革层附着在泡沫覆盖的胴体上。

    Management system of monitor wafers
    12.
    发明授权
    Management system of monitor wafers 有权
    监控晶圆管理系统

    公开(公告)号:US06865434B1

    公开(公告)日:2005-03-08

    申请号:US10707626

    申请日:2003-12-25

    CPC classification number: G05B19/41875 G05B2219/45031 G06Q10/087 Y02P90/22

    Abstract: A management system for managing information of monitor wafers stored in a storage center includes an operation rule module for determining the next manufacturing process for each of the monitor wafers according to its wafer number and wafer condition, an information update module for updating the information of the monitor wafers in a database according to the results made by the operation rule module, an inventory module for computing an inventory quantity of the monitor wafers according to the wafer numbers and the wafer conditions of the monitor wafers, a warning module for checking whether the inventory quantity of the monitor wafers is less than the quantity of the safety stock or not and sending a warning message when the inventory quantity of the monitor wafers is less than the quantity of the safety stock, and a display module for showing the wafer conditions and the inventory quantity of the monitor wafers.

    Abstract translation: 用于管理存储在存储中心中的监视晶片的信息的管理系统包括:操作规则模块,用于根据其晶片数量和晶片状况确定每个监视晶片的下一个制造过程;信息更新模块,用于更新 根据操作规则模块的结果监视数据库中的晶片,根据晶片数量和监视晶片的晶片条件来计算监视晶片的库存量的库存模块,用于检查库存的警告模块 显示器晶片的数量少于安全库存量,并且当监视晶片的库存量小于安全库存量时发送警告消息,以及用于显示晶片状态的显示模块和 显示晶片的库存量。

    Method for adjusting a tilt angle for an optical disc player
    13.
    发明授权
    Method for adjusting a tilt angle for an optical disc player 失效
    调整光盘播放机的倾斜角度的方法

    公开(公告)号:US06862257B2

    公开(公告)日:2005-03-01

    申请号:US10383483

    申请日:2003-03-07

    CPC classification number: G11B7/082

    Abstract: The present invention discloses a method for adjusting a tilt angle of an optical disc driver. The method includes the following steps. First, to move the optical pick up to close the outer end of the first and second guiding shafts. Next, the turntable drives a disc to rotate. Then, the light source provides a light to penetrate through the disc and the lens. The image sensor receives the reflection light from the disc and the lens. The monitor displays the traces projected from the reflection lights. According to the traces, the driving device adjusts the positions of the first and second guiding shafts.

    Abstract translation: 本发明公开了一种调整光盘驱动器的倾斜角度的方法。 该方法包括以下步骤。 首先,移动光学拾取器以闭合第一和第二引导轴的外端。 接下来,转盘驱动盘旋转。 然后,光源提供穿透盘和透镜的光。 图像传感器接收来自盘和透镜的反射光。 监视器显示从反射灯投影的踪迹。 根据轨迹,驱动装置调节第一和第二引导轴的位置。

    Compounds for the treatment of hepatoma
    15.
    发明授权
    Compounds for the treatment of hepatoma 失效
    用于治疗肝癌的化合物

    公开(公告)号:US5981774A

    公开(公告)日:1999-11-09

    申请号:US948264

    申请日:1997-10-09

    CPC classification number: C07D407/14 A61K31/352

    Abstract: Compounds of general Formula I in which the substituents of R.sub.1 -R.sub.7 are hydrogen, hydroxy group, C.sub.1-6 alkyl group, C.sub.1-6 alkoxy group, or epoxypropoxy, but at the most, six of the substituents can simultaneously be hydrogen, methoxy group, or hydroxy group, or epoxypropoxy group for activity against hepatoma. There are also described processes for the preparation of the novel compounds and useful intermediates. Substitute benzophenones are described.

    Abstract translation: 其中R 1 -R 7的取代基是氢,羟基,C 1-6烷基,C 1-6烷氧基或环氧丙氧基,但最多六个取代基的通式I的化合物可以同时为氢,甲氧基 ,或羟基,或环氧丙氧基用于抗肝癌活性。 还描述了制备新化合物和有用的中间体的方法。 描述了替代二苯甲酮。

    Synthesis and pharmacological activity of a series of novel xanthone
derivatives
    16.
    发明授权
    Synthesis and pharmacological activity of a series of novel xanthone derivatives 失效
    一系列新型呫吨酮衍生物的合成和药理活性

    公开(公告)号:US5495005A

    公开(公告)日:1996-02-27

    申请号:US112704

    申请日:1993-08-26

    CPC classification number: C07H17/04 C07C45/46 C07C49/84 C07D311/86

    Abstract: A compound, and salts thereof, represented by either formula I or formula II below:(1) Formula I: ##STR1## wherein substituents R.sub.1 -R.sub.7 can be, independently, hydrogen, hydroxy group, C.sub.1-6 alkyl(oxy) group, acetyl ester, or C.sub.1-12 alkyl propanolamine; at least three but no more than four of the substituents are alkyl(oxy) group, hydroxyl group or acetyl ester; no more than one of the substituents can be C.sub.1-12 alkyl propanolamines; R.sub.1, R.sub.3, R.sub.7 cnnnot all be hydroxy groups at the same time; and R.sub.6 is either an hydroxy group or an oxygen-containing glucose.(2) Formula II: ##STR2## wherein substituents R.sub.1 -R.sub.9 can be, indenpendently, hydrogen, hydroxy group and C.sub.1-6 alkyl(oxy) group; and no more then four of the substituents can be methoxy group, hydroxy group, or acetyl ester. These compounds were tested to be capable of inhibiting platelet aggregation, atrioventricular conduction, and calcium influx in myocardiac cells.

    Abstract translation: 由下式I或式II表示的化合物及其盐:(1)式I:有侧链,氢,羟基,C 1-6烷基(氧基),乙酰基酯或C 1-12烷基丙醇胺; 至少三个但不超过四个取代基是烷基(氧基),羟基或乙酰基酯; 不超过一个取代基可以是C 1-12烷基丙醇胺; R1,R3,R7不同时为羟基; R6为羟基或含氧葡萄糖。 (2)式II:其中取代基R 1 -R 9可以是氢,羟基和C 1-6烷基(氧基)基团; 并且不超过4个取代基可以是甲氧基,羟基或乙酰基酯。 测试这些化合物能够抑制心肌细胞中的血小板聚集,房室传导和钙流入。

    Artificial Saliva with Electrolytes for Xerostomia

    公开(公告)号:US20210169777A1

    公开(公告)日:2021-06-10

    申请号:US17106132

    申请日:2020-11-29

    Applicant: Chun Nan Lin

    Inventor: Chun Nan Lin

    Abstract: The present invention provides an orally ingestible composition comprising electrolytes, Methyl Hydroxybenzoate, and sorbitol for treating xerostomia (dry mouth) and associated disorders, with very good results in provide a protective coating inside the mouth and throat, in alleviating the symptoms of xerostomia, including difficulties in eating and speaking, the pain associated to xerostomia, improving the quality of life on affected people as well. Sweeteners, colorants, and preservatives also combined in the artificial saliva. Methyl Hydroxybenzoate acts as a lubricant and as a delivery vehicle for water from the composition to moisten the mouth. The artificial saliva composition is used to keep moisture in the mouth when there is little or no natural saliva is produced, providing relief from dry mouth, as a symptom of xerostomia, mucositis, and stomatitis, as well as general inflammation and/or ulceration of mucous membranes, while avoiding pH imbalances which may lead secondary to tooth decay and/or injury to the upper digestive tract including the oral cavity, oropharynx, or esophagus. The pH buffering system includes acidic and basic components. The electrolytes include potassium, sodium, magnesium, calcium, chloride and phosphate together with fluoride. The composition of the invention has also been proved in clinically to prevent demineralization from acid conditions and decreasing risk of oral thrush. The composition of the invention can apply by persons with certain diseases, such as some cancers, radiation, chemotherapy, old age, smoking, and both prescribed and over the counter medications with side effect.

    Image-recognition method for assisting ophthalmic examination instrument
    19.
    发明授权
    Image-recognition method for assisting ophthalmic examination instrument 有权
    辅助眼科检查仪的图像识别方法

    公开(公告)号:US08781190B2

    公开(公告)日:2014-07-15

    申请号:US13584262

    申请日:2012-08-13

    CPC classification number: G06T5/008 G06K9/3233 G06T2207/30041

    Abstract: An image-recognition assisting method includes the steps of using an examination instrument to generate an image having a split-image area formed thereon; setting a region-of-interest (ROI) around the split-image area of the generated image; performing a pixel luminance addition processing on the ROI, so that all pixels in the ROI have increased luminance contrast; and performing a contrast correction on the ROI having increased luminance contrast, so that the luminance contrast between the split-image area and the area surrounding the split-image area in the ROI is further increased. The image-recognition assisting method optimizes the image generated by the conventional ophthalmic examination instrument, such as a fundus camera, to increase the sharpness and the luminance contrast of the image output by the fundus camera, so that an examiner can easily recognize two offset rectangular image parts in the split-image area and align them with each other to focus the examination instrument.

    Abstract translation: 图像识别辅助方法包括以下步骤:使用检查仪器生成其上形成有分割图像区域的图像; 在生成的图像的分割图像区域周围设置感兴趣区域(ROI); 对ROI进行像素亮度附加处理,使得ROI中的所有像素具有增加的亮度对比度; 并且对具有增加的亮度对比度的ROI执行对比度校正,使得分割图像区域和ROI中的分割图像区域周围的区域之间的亮度对比度进一步增加。 图像识别辅助方法优化诸如眼底照相机的常规眼科检查仪产生的图像,以增加由眼底照相机输出的图像的清晰度和亮度对比度,使得检查者可以容易地识别两个偏移矩形 在分割图像区域中的图像部分并将它们彼此对准以对准检查仪器。

Patent Agency Ranking